The development of an optimized bioprocess requires a holistic approach tailored to the specific needs of the product.
Industry stakeholders are coming together to share knowledge and expertise, explore new processes, and advance a culture of innovation.
Current production systems can generate high titers of adenovirus, however, adenoviral vectors are tricky to purify on any significant scale despite their availability and abundance.
There are simple and straightforward chromatography maintenance tips involving sample preparation, buffers, columns and the overall system to keep your experiments humming along.
Using scale-up strategies that consider certain challenges, in combination with truly scalable bioreactor equipment can offer efficient approaches to scaling-up bioprocesses from early development to final production.
A company has to be able to withstand the highs and lows of biologics development. To avoid costly mistakes and wasted efforts, a company must prepare for surprises along the drug development pathway.
Adenovirus vectors are effective tools for the transfer of genetic material into mammalian cells. Their qualities have led them to be the most used gene transfer vectors in experimental therapies.
What strategies should your company consider for recruiting, training, and retaining qualified candidates in order to remain competitive in a burgeoning biopharma market?
There are numerous solutions available to ensure effective process validation at sites within a global network. No matter the solution, a comprehensive process validation strategy is necessary.
This article captures high-level learning about the use of SUTs in biopharmaceutical manufacturing that can be applied to CGTs, with a special focus on connection technologies.
|
|
|
|
|
|
|
|
|